exhibit

Exhibit roadmap

Status: Stage 0 acceptance complete; distribution readiness pending

Last reviewed: 2026-07-30

Exhibit should close the approved version 0.1 contract before expanding its feature surface. Each stage has an exit condition; passing tests alone does not substitute for user or owner decisions.

Stage 0 — internal release candidate

Goal: make the existing approved scope internally complete.

Exit condition: every automated gate passes, the artifact is recorded, and all eight approved acceptance criteria are complete.

The manual acceptance record is complete. Before publication, the current working tree still needs to become a clean release commit with a newly generated and recorded artifact.

Stage 1 — distribution readiness

Goal: create a product that can legally and operationally be offered.

Exit condition: owner signs the launch checklist and the final store package matches reviewed documentation.

Validation note, 2026-07-30: listing copy, policy drafts, permission justifications, screenshot automation, and package automation exist. They do not complete the unchecked owner decisions, public contact/hosting work, compatibility matrix, independent review, or final publisher-form review.

Stage 2 — problem and segment validation

Goal: test whether frontend developers on Next.js applications are the right initial segment.

Exit condition: observed evidence supports or rejects the proposed wedge and defines the next usability work.

Validation note, 2026-07-30: the repository contains measures and a proposed segment, but no participant record or observed research evidence. None of the Stage 2 items can yet be marked complete.

Stage 3 — differentiated workflow

Goal: deepen the validated advantage, not copy competitor breadth.

Candidate work, ordered only after Stage 2 evidence:

Explicitly deferred until separate evidence and privacy design exist:

Decision log required

Before moving stages, record:

  1. evidence reviewed;
  2. decision owner;
  3. accepted trade-offs;
  4. privacy and permission impact;
  5. measurable exit condition.

Current product and commercial hypotheses live in PRODUCT.md and BUSINESS_MODEL.md. Competitor evidence lives in COMPETITIVE_LANDSCAPE.md.